Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 2

Conditions

Pituitary Neoplasms 2Dwarfism, Pituitary 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pituitary Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metabolic Syndrome 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Hypopituitarism 1Atherosclerosis 1

Interventions

pasireotide 7Cabergoline 7Surgical Procedures, Operative 4Temozolomide 3Propofol 3Hydrocortisone 3Dexmedetomidine 3lanreotide 2Sevoflurane 2Saline Solution 2Rosiglitazone 2Radiotherapy 2Radiosurgery 2Proton Therapy 2Octreotide 2Human Growth Hormone 2Dexamethasone 2Desflurane 2Aminolevulinic Acid 2pegvisomant 1parecoxib 1lutetium Lu 177 dotatate 1loxoprofen 1farletuzumab 1entinostat 1corticorelin ovine 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Visual Field Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Human Growth Hormone × Clear all
NCT00136032 2008-02-18

Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women

Massachusetts General Hospital

Phase NA Completed
63 enrolled
Endocrine

Dwarfism, Pituitary, Pituitary Diseases, Pituitary Neoplasms

NCT00462475 2007-10-16

5yrGH

Federico II University

Completed
20 enrolled
Endocrine

Dwarfism, Pituitary, Hypopituitarism, Pituitary Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡